机会均等
帮助
动画
机会均等

LabCorp is Scheduled to Present at the Cowen and Company 7th Annual Global Health Care Conference

3 November 2006

BURLINGTON, N.C., Nov. 3 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that David P. King, Executive Vice President and Chief Operating Officer, Bradford T. Smith, Executive Vice President, Corporate Affairs, and William (Brad) Hayes, Executive Vice President and Chief Financial Officer, are scheduled to speak at the Cowen and Company 7th Annual Health Care Conference in London, UK. LabCorp's presentation is planned for Tuesday, November 7, 2006 at 1:45 p.m. (Greenwich Mean Time).

A live audio webcast of the presentation will be available via the Company Web site at www.labcorp.com and archived for replay.

About LabCorp

Laboratory Corporation of America(R) Holdings, a S&P 500 company, is a pioneer in commercializing new diagnostic technologies and the first in its industry to embrace genomic testing. With annual revenues of $3.3 billion in 2005, approximately 24,000 employees nationwide, and more than 220,000 clients, LabCorp offers clinical assays ranging from routine blood analyses to HIV and genomic testing. LabCorp combines its expertise in innovative clinical testing technology with its Centers of Excellence: The Center for Molecular Biology and Pathology, in Research Triangle Park, NC; National Genetics Institute, Inc. in Los Angeles, CA; ViroMed Laboratories, Inc. based in Minneapolis, MN; The Center for Esoteric Testing in Burlington, NC; DIANON Systems, Inc. based in Stratford, CT; US LABS based in Irvine, CA; and Esoterix and its Colorado Coagulation, Endocrine Sciences, and Cytometry Associates laboratories. LabCorp clients include physicians, government agencies, managed care organizations, hospitals, clinical labs, and pharmaceutical companies. To learn more about our growing organization, visit our Web site at: www.LabCorp.com.

Each of the above forward-looking statements is subject to change based on various important factors, including without limitation, competitive actions in the marketplace and adverse actions of governmental and other third-party payors. Actual results could differ materially from those suggested by these forward-looking statements. Further information on potential factors that could affect LabCorp's financial results is included in the Company's Form 10- K for the year ended December 31, 2005, and subsequent SEC filings.

SOURCE  Laboratory Corporation of America Holdings
    -0-                             11/03/2006
    /CONTACT:  Investors, Scott Fleming, +1-336-436-4879, or Media, Pam
Sherry, +1-336-436-4855, or Shareholder Direct, +1-800-LAB-0401/
    /Web site:  http://www.labcorp.com/
    (LH)

CO:  Laboratory Corporation of America Holdings; Cowen and Company 7th Annual
     Health Care Conference
ST:  North Carolina, England
IN:  HEA MTC BIO
SU:  CCA MAV

BC-FB
-- CLF012 --
5778 11/03/2006 08:17 EST http://www.prnewswire.com